ENTITY
Frontage Holdings

Frontage Holdings (1521 HK)

59
Analysis
Health CareChina
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Refresh
07 Oct 2019 16:03

HK Connect Flows: Activities Amid Inactivity Before Golden Week (2019-10-04)

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
419 Views
Share
bullishSmartkarma
12 Sep 2019 15:33

Hong Kong IPO Analytics - Regular Cornerstone Investors and Track Record

At the beginning of this year, we at Aequitas Research, wrote on IPO analytics of deals across Asia-Pacific from 2016 to 2018. If you have not read...

Share
29 Aug 2019 20:55

Pharmaron Beijing IPO Initiation: Clinically Sound

Pharmaron Beijing Co., Ltd. (A) (300759 CH) is a global contract research organisation (CRO) and is one of the top three drug discovery service...

Logo
527 Views
Share
05 Aug 2019 11:11

HK IPO Analytics 1H2019: MS and CICC Stand Out

At the beginning of this year, we at Aequitas Research wrote on IPO analytics of deals across Asia-Pacific from 2016 to 2018. If you have not read...

Logo
598 Views
Share
25 Jul 2019 15:56

HK IPO Analytics 1H2019: Healthcare and Consumer Discretionary Stand Out

At the beginning of this year, we at Aequitas Research wrote on IPO analytics of deals across Asia-Pacific from 2016 to 2018. If you have not read...

Logo
526 Views
Share
x